We are live on ! Find out more
ABMD

Abiomed Inc

Delisted

ABMD was delisted on the 21st of December, 2022.

305 hedge funds and large institutions have $5.1B invested in Abiomed Inc in 2016 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 107 increasing their positions, 114 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

37% more call options, than puts

Call options by funds: $29M | Put options by funds: $21.1M

26% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 35

13% more funds holding in top 10

Funds holding in top 10: 89 (+1)

12% more capital invested

Capital invested by funds: $4.54B → $5.1B (+$554M)

3% more funds holding

Funds holding: 297305 (+8)

6% less repeat investments, than reductions

Existing positions increased: 107 | Existing positions reduced: 114

Holders
305
Holders Change
+8
Holders Change %
+2.69%
% of All Funds
8.14%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.24%
New
44
Increased
107
Reduced
114
Closed
35
Calls
$29M
Puts
$21.1M
Net Calls
+$7.9M
Net Calls Change
+$3.52M
Name Holding Trade Value Shares
Change
Change in
Stake
Primecap Management
1
Primecap Management
California
$605M -$35.7M -297,900 -6%
Vanguard Group
2
Vanguard Group
Pennsylvania
$400M +$39.4M +328,830 +12%
PAI
3
Palo Alto Investors
California
$242M -$21.9M -182,535 -9%
BFA
4
BlackRock Fund Advisors
California
$210M +$8M +66,809 +4%
EWM
5
Essex Woodlands Management
Texas
$186M
BIT
6
BlackRock Institutional Trust
California
$151M +$1.94M +16,224 +1%
1832 Asset Management
7
1832 Asset Management
Ontario, Canada
$141M +$132K +1,100 +0.1%
State Street
8
State Street
Massachusetts
$141M +$1.87M +15,596 +1%
Wellington Management Group
9
Wellington Management Group
Massachusetts
$129M +$61.5M +513,614 +105%
Lord, Abbett & Co
10
Lord, Abbett & Co
New Jersey
$111M +$3.82M +31,916 +4%
William Blair Investment Management
11
William Blair Investment Management
Illinois
$97.3M -$6.76M -56,433 -7%
JSP
12
Jackson Square Partners
California
$86M -$68.3M -569,880 -46%
Renaissance Technologies
13
Renaissance Technologies
New York
$84.9M +$4.61M +38,500 +6%
ORI
14
Oak Ridge Investments
Illinois
$78.6M -$5.58M -46,547 -7%
BCM
15
Brown Capital Management
Maryland
$77.7M +$1.2M +10,005 +2%
Goldman Sachs
16
Goldman Sachs
New York
$75.6M +$4.47M +37,293 +7%
Baillie Gifford & Co
17
Baillie Gifford & Co
United Kingdom
$74M -$2.77M -23,110 -4%
Arrowstreet Capital
18
Arrowstreet Capital
Massachusetts
$70.6M +$35.8M +299,201 +120%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$70.5M +$5.95M +49,638 +10%
EAM
20
Eagle Asset Management
Florida
$70.3M -$25.3M -211,405 -28%
Royal Bank of Canada
21
Royal Bank of Canada
Ontario, Canada
$65M -$7.65M -63,904 -11%
Macquarie Group
22
Macquarie Group
Australia
$64.3M -$134M -1,119,014 -69%
Norges Bank
23
Norges Bank
Norway
$63.1M
Janus Henderson Group
24
Janus Henderson Group
United Kingdom
$62.9M +$155K +1,294 +0.3%
SI
25
Scout Investments
Missouri
$59.3M +$23M +192,214 +71%

ABMD Hedge Fund Activity: Q3 2016 in Review

305 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q3 2016, worth a combined $5.1B — up 12% from $4.54B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new ABMD positions and 35 closed out — a net gain of 9 holders — while 107 added to existing stakes and 114 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $61.5M. The largest seller was Macquarie Group, cutting an estimated $134M.

  • 305 institutional investors held Abiomed Inc (ABMD) as of Q3 2016, up from 297 in Q2 2016.
  • Funds reported $5.1B of Abiomed Inc stock for Q3 2016, up 12% quarter-over-quarter.
  • 44 funds opened new Abiomed Inc positions in Q3 2016 and 35 closed out, a net change of +9 holders.
  • The largest Abiomed Inc buyer in Q3 2016 was Wellington Management Group, an estimated $61.5M added.
  • The largest Abiomed Inc seller in Q3 2016 was Macquarie Group, an estimated $134M sold.

Based on aggregated 13F filings for Q3 2016.